News

Public · Published

Prediction markets land on ESMA radar over insider trading, authorization questions

The European Securities and Markets Authority (ESMA) stated that prediction market platforms Polymarket and Kalshi lack the required authorization to sell event contracts to users in the European Union. Several countries are moving to regulate or ban such platforms over insider trading and manipulation concerns.

Published:

Updated:

What happened

The European Securities and Markets Authority (ESMA) stated that prediction market platforms Polymarket and Kalshi lack the required authorization to sell event contracts to users in the European Union. Several countries are moving to regulate or ban such platforms over insider trading and manipulation concerns.

Confirmed

Global impact / market context

If ESMA enforces this, these platforms may lose access to EU customers, reducing their revenue. This could also push other prediction markets to seek licenses or exit the region, affecting investors who use them for hedging or speculation.

Analyst inference

Prediction markets are growing but face regulatory crackdowns globally. Stricter rules could raise compliance costs for platforms, potentially reducing trading volumes and investor interest. This may also encourage more regulated alternatives, like traditional exchanges, to offer similar products.

Analyst inference

What to watch

  1. Watch for official ESMA decisions or statements on whether Polymarket and Kalshi will be required to stop offering event contracts to EU users, as this would directly impact their operations. Confirmed
  2. Consider monitoring whether these platforms apply for authorization in the EU or adjust their services to comply with local regulations, which could signal their long-term commitment to the region. Proposed
  3. Observe if other countries follow with bans or regulations, as this could create a domino effect, reducing the total addressable market for prediction platforms and affecting their valuation. Analyst inference

Evidence